Short-term efficacy of unibody single-branched stent in the treatment of lesions involving the left subclavian artery: two-year follow-up outcomes
Bai-Lang CHEN1
Xian-Mian ZHUANG2
Min-Xin WEI2
1.Department of Cardiovascular Surgery, the Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China2.Department of Cardiovascular Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen, China
摘要：The development of thoracic endovascular aortic repair (TEVAR) technology avoids the risk of patients opening the chest and is widely used in Stanford B-type dissection.[1-3] However,because TEVAR technology has clear requirements for vascular anatomy of the lesion,it limits its application to some patients.In the shortcomings of the proximal anchor zone,coverage of the left subclavian artery (LSA) origin without revascularization during TEVAR appears to have increased risk of stroke,upper extremity ischemia and paraplegia.[4]
机标关键词：
论文发表日期：2020-02-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：4( 120-123 )
英文信息